Windtree Therapeutics, Inc. Profile Avatar - Palmy Investing

Windtree Therapeutics, Inc.

Windtree Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of acute cardiovascular and secondarily in acute pulmonary diseases. The company's lead development programs include ist…

Biotechnology
US, Warrington [HQ]
Revenue Breakdowns

Segment Analysis Beta

The financial segments are sourced from the SEC' 10-K statement.

Revenue By Top Segments

Windtree Therapeutics, Inc. can't present it's sankey chart.

Historical Revenue By Segment

Last 3Y, in million USD

Windtree Therapeutics, Inc. can't present revenue by segment

Get PRO Today

With PRO you can bypass the blur for the segment revenues of Windtree Therapeutics, Inc..

If you want to see a demo, head over to the financial segments of AAPL

End of WINT's Analysis
CIK: 946486 CUSIP: 97382D303 ISIN: US97382D4025 LEI: - UEI: -
Secondary Listings
WINT has no secondary listings inside our databases.